ArticleBioengineering (Basel, Switzerland)2025
A Changepoint Detection-Based General Methodology for Robust Signal Processing: An Application to Understand Preeclampsia's Mechanisms.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Motivated by illuminating the underlying mechanisms of preeclampsia, we develop a changepoint detection-based general and versatile methodology that can be applied to any experimental model, effectively addressing the challenges of high uncertainty produced by experimental interventions, intrinsic high variability, and rapidly and abruptly varying time dynamics in perfusion signals. This methodology provides a systematic and reliable approach for robust perfusion signal analysis. The main innovation of our methodology is a highly efficient automatic data processing system consisting of modular programming components. These components include a signal processing tool for optimal segmentation of perfusion signals by isolating their "genuine" vascular response to experimental interventions, and a novel and suitable normalization to evaluate this response concerning an experimental reference state, typically basal or pre-intervention. In this way, we can identify anomalies in an experimental group compared to a control group by disaggregating noise during the transitions just after experimental interventions. We have successfully applied our general methodology to perfusion signals measured from a preeclampsia-like syndrome model developed by our research group. Our findings revealed impaired brain perfusion in offspring from preeclampsia, particularly dysfunctional brain perfusion signals with inadequate perfusion signal vasoreactivity to thermal physical stimuli. This general methodology represents a significant step towards a systematic, accurate, and reliable approach to robust perfusion signals analysis across various experimental settings with diverse intervention protocols.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.